Amdocs (NASDAQ:DOX) Hits New 52-Week Low – Time to Sell?

Amdocs Limited (NASDAQ:DOX)’s share price reached a new 52-week low during mid-day trading on Friday . The company traded as low as $65.45 and last traded at $65.6310, with a volume of 88792 shares. The stock had previously closed at $66.92.

Analysts Set New Price Targets

Several research firms have commented on DOX. Stifel Nicolaus dropped their price target on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, February 4th. Barclays decreased their target price on Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a report on Wednesday, February 4th. Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a research report on Tuesday, January 27th. Finally, Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

Amdocs Stock Down 1.9%

The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.23. The stock has a market cap of $7.09 billion, a PE ratio of 12.70, a price-to-earnings-growth ratio of 1.18 and a beta of 0.42. The firm has a fifty day moving average of $75.35 and a 200 day moving average of $79.38.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The company had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.15 billion. During the same period in the previous year, the business earned $1.66 EPS. Amdocs’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. On average, equities research analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be paid a $0.569 dividend. This is an increase from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 annualized dividend and a yield of 3.5%. The ex-dividend date is Tuesday, March 31st. Amdocs’s payout ratio is currently 40.81%.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. LSV Asset Management boosted its position in shares of Amdocs by 7.6% in the 3rd quarter. LSV Asset Management now owns 3,648,703 shares of the technology company’s stock valued at $299,376,000 after purchasing an additional 257,193 shares during the period. Illinois Municipal Retirement Fund lifted its stake in Amdocs by 46.6% in the third quarter. Illinois Municipal Retirement Fund now owns 149,539 shares of the technology company’s stock valued at $12,270,000 after buying an additional 47,537 shares during the last quarter. New York State Common Retirement Fund lifted its stake in Amdocs by 20.3% in the third quarter. New York State Common Retirement Fund now owns 554,401 shares of the technology company’s stock valued at $45,489,000 after buying an additional 93,527 shares during the last quarter. Alps Advisors Inc. boosted its holdings in shares of Amdocs by 11.6% in the third quarter. Alps Advisors Inc. now owns 237,883 shares of the technology company’s stock valued at $19,518,000 after acquiring an additional 24,771 shares during the period. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Amdocs by 13.6% in the second quarter. JPMorgan Chase & Co. now owns 266,124 shares of the technology company’s stock valued at $24,281,000 after acquiring an additional 31,827 shares during the period. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.